Oragenics (OGEN) News Today → My #1 investment for 2024 (From True Market Insiders) (Ad) Free OGEN Stock Alerts $2.33 +0.69 (+42.07%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 18 at 3:40 AM | americanbankingnews.comOragenics (NYSE:OGEN) Research Coverage Started at StockNews.comMay 17 at 8:00 AM | globenewswire.comOragenics, Inc. to Host Webinar Panel on Neurotrauma MedicineMay 16 at 12:42 PM | msn.comOragenics climbs 9% amid Phase 2 study, business updatesMay 16 at 9:58 AM | finance.yahoo.comOragenics, Inc. Prepares Intranasal Pharmaceutical, ONP-002, for Phase II Concussion TrialMay 16 at 12:06 AM | investorplace.comOGEN Stock Earnings: Oragenics Reported Results for Q1 2024May 11, 2024 | finance.yahoo.comOragenics, Inc. (OGEN)May 7, 2024 | msn.comOragenics partners with Avance Clinical for Phase 2 concussion studyMay 7, 2024 | finance.yahoo.comOragenics Partners with Avance Clinical for Phase II Concussion Trial in AustraliaApril 27, 2024 | finance.yahoo.comOragenics, Inc. (OGEN) Stock Price, News, Quote & History - Yahoo FinanceApril 20, 2024 | finance.yahoo.comOdyssey Health, Inc. (ODYY)April 19, 2024 | businesswire.comOragenics, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing StandardsApril 17, 2024 | money.usnews.comOragenics IncApril 16, 2024 | ca.finance.yahoo.comOragenics, Inc. (OGEN) Latest Stock News & Headlines - Yahoo FinanceApril 1, 2024 | finance.yahoo.comOragenics, Inc. Files 10K and Provides Company UpdateMarch 18, 2024 | markets.businessinsider.comOragenics Appoints Kelly As Chief Medical OfficerMarch 17, 2024 | finance.yahoo.com15 Highest Quality Probiotics For Gut HealthMarch 5, 2024 | businesswire.comOragenics, Inc. Prepares Drug for Phase II Clinical Trials to Treat ConcussionMarch 1, 2024 | businesswire.comOragenics Announces Closing of Public OfferingMarch 1, 2024 | uk.investing.comOragenics announces public stock offeringFebruary 28, 2024 | investorplace.comWhy Is Oragenics (OGEN) Stock Down 45% Today?February 27, 2024 | markets.businessinsider.comOragenics Prices Public Offering Of 1.40 Mln Shares At $1.50/shr; Stock PlungesFebruary 27, 2024 | businesswire.comOragenics Announces Pricing of Public OfferingFebruary 27, 2024 | marketwatch.comOragenics Shares Fall After Proposed Public OfferingFebruary 27, 2024 | businesswire.comOragenics Announces Proposed Public OfferingFebruary 12, 2024 | marketwatch.comOragenics CEO Murphy Leaves, President Redmond Named Interim ReplacementFebruary 12, 2024 | finance.yahoo.comOragenics, Inc. Announces Leadership TransitionFebruary 7, 2024 | finance.yahoo.comOragenics, Inc. Announces Expiration of Its Investment Banking Engagement AgreementFebruary 5, 2024 | finance.yahoo.comOragenics, Inc. Preparing for Phase II Clinical Trials to Treat ConcussionJanuary 23, 2024 | msn.comOragenics terminates ATM offering program; shares jumpJanuary 23, 2024 | finance.yahoo.comOragenics Announces Termination of At-The-Market Offering ProgramJanuary 6, 2024 | seekingalpha.comOGEN, RLMD and ATXI among mid-day moversJanuary 2, 2024 | financialpost.comOragenics Completes Acquisition of Odyssey Health’s Neurological AssetsDecember 12, 2023 | finanznachrichten.deOdyssey Health, Inc. Gains Shareholder Approval for Asset Sale with Oragenics, Inc.November 6, 2023 | finance.yahoo.comOragenics, Inc. (UAV.F)November 2, 2023 | finance.yahoo.comOragenics Issues Update to ShareholdersOctober 5, 2023 | marketwatch.comOragenics Shares Rise 15% After Deal to Buy Some Odyssey Health AssetsOctober 5, 2023 | finance.yahoo.comOragenics to Acquire Odyssey Health’s Neurological Drug Technology Pipeline Including Concussion Drug CandidateOctober 2, 2023 | msn.comOragenics, AVITA Medical among healthcare moversSeptember 29, 2023 | marketwatch.comStocks to Watch: Oragenics, Natuzzi, Syndax PharmaceuticalsSeptember 29, 2023 | finance.yahoo.comOragenics Enters into Agreement with Lantern Bioworks for Replacement-Therapy AssetsAugust 7, 2023 | finance.yahoo.comOragenics, Inc. Announces Private PlacementJune 5, 2023 | finance.yahoo.comOragenics Project to Develop a Variant-Agnostic Protein Antigen for Use in its COVID-19 Intranasal Vaccine Receives Funding from CQDMMarch 29, 2023 | finance.yahoo.comOragenics to Participate in the World Vaccine Congress WashingtonMarch 14, 2023 | finance.yahoo.comOragenics Announces Positive Results in Several Lantibiotics Compounds Against MRSA and VREMarch 8, 2023 | finance.yahoo.comOragenics Appoints Janet Huffman as Chief Financial Officer Strengthening Executive Leadership TeamMarch 1, 2023 | finance.yahoo.comOragenics Looks To Boost Potency Of Its Nasal COVID-19 Vaccine With New Licensing PactMarch 1, 2023 | finance.yahoo.comOragenics Enters into an Exclusive Global License Agreement with Inspirevax to Develop Intranasal Covid Vaccine CandidateFebruary 3, 2023 | financialpost.comOragenics, Inc. Regains Compliance with NYSE AmericanDecember 23, 2022 | finance.yahoo.comOragenics, Inc. Discloses One-for-Sixty Reverse Stock SplitDecember 22, 2022 | finance.yahoo.comOragenics Reports Favorable Toxicology Results for its COVID-19 Intranasal Vaccine Candidate Get Oragenics News Delivered to You Automatically Sign up to receive the latest news and ratings for OGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address My #1 investment for 2024 (Ad)It’s something you use every single day and don’t even know it. Click here to see my #1 investment for 2024. OGEN Media Mentions By Week OGEN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OGEN News Sentiment▼0.230.50▲Average Medical News Sentiment OGEN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OGEN Articles This Week▼60▲OGEN Articles Average Week Get Oragenics News Delivered to You Automatically Sign up to receive the latest news and ratings for OGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: eFFECTOR Therapeutics News Today Virios Therapeutics News Today Can-Fite BioPharma News Today Bionomics News Today Vaxxinity News Today Trevena News Today Hepion Pharmaceuticals News Today Cadrenal Therapeutics News Today Shuttle Pharmaceuticals News Today Pasithea Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:OGEN) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceWhat’s Really Next for America…Porter & Company[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyMissed NVDA? Buy this AI stock NOWChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oragenics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
